These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24652591)

  • 1. The role of RCAS1 as a biomarker in diagnosing CRC and monitoring tumor recurrence and metastasis.
    Han SX; Wang J; Wang LJ; Jin GH; Ying X; He CC; Guo XJ; Zhang JY; Zhang Y; Zhu Q
    Tumour Biol; 2014 Jun; 35(6):6149-57. PubMed ID: 24652591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The utility of serum receptor-binding cancer antigen expressed on SiSo cells in gastrointestinal tract cancers.
    Coban S; Ozkan H; Köklü S; Yüksel O; Koçkar MC; Akar T; Ormeci N
    Can J Gastroenterol; 2006 Sep; 20(9):593-6. PubMed ID: 17001401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of soluble receptor-binding cancer antigen expressed on SiSo cells and carcinoembryonic antigen in differentiating malignant from benign pleural effusion.
    Dong J; Sun G; Zhu H
    Tumour Biol; 2016 Mar; 37(3):3257-64. PubMed ID: 26438059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Predictive value of combination detection of tissue Pgp1 expression and preoperative serum CEA level for colorectal cancer].
    Wu F; Chen L; Wu W; Jiang B; Su X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):443-449. PubMed ID: 28440527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum receptor-binding cancer antigen expressed on SiSo cells (RCAS1) as a diagnostic and prognostic marker for non-small cell lung cancer.
    Xu C; Yu LK; Zhang X
    Tumori; 2014; 100(4):107e-11e. PubMed ID: 25296600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of carcinoembryonic antigen (CEA), epidermal growth factor receptor (EGFR), epithelial cell adhesion molecule EpCAM (GA733-2), and carbohydrate antigen 19-9 (CA 19-9) levels in colorectal cancer patients and correlation with clinicopathological characteristics.
    Mourtzikou A; Stamouli M; Kroupis C; Christodoulou S; Skondra M; Kastania A; Pectasides D; Athanasas G; Dimas C
    Clin Lab; 2012; 58(5-6):441-8. PubMed ID: 22783573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of mannose receptor and CD163 as novel biomarkers for colorectal cancer.
    Ding D; Yao Y; Yang C; Zhang S
    Cancer Biomark; 2018 Feb; 21(3):689-700. PubMed ID: 29226859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of tumour associated antigen RCAS1 is implicated in high stages of colorectal cancer.
    Leelawat K; Watanabe T; Nakajima M; Tujinda S; Suthipintawong C; Leardkamolkarn V
    J Clin Pathol; 2003 Oct; 56(10):764-8. PubMed ID: 14514780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Cyr61 as a potential biomarker for diagnosis of colorectal cancer.
    Song YF; Xu ZB; Zhu XJ; Tao X; Liu JL; Gao FL; Wu CL; Song B; Lin Q
    Clin Transl Oncol; 2017 Apr; 19(4):519-524. PubMed ID: 27743169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic utility of serum receptor-binding cancer antigen expressed on SiSo cells (RCAS1) levels in colon cancer patients.
    Giaginis C; Margeli A; Kouraklis G; Zira A; Tsourouflis G; Theocharis S
    Int J Biol Markers; 2009; 24(2):70-6. PubMed ID: 19634109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-34a-5p suppresses colorectal cancer metastasis and predicts recurrence in patients with stage II/III colorectal cancer.
    Gao J; Li N; Dong Y; Li S; Xu L; Li X; Li Y; Li Z; Ng SS; Sung JJ; Shen L; Yu J
    Oncogene; 2015 Jul; 34(31):4142-52. PubMed ID: 25362853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of serum RCAS1 levels detected by monoclonal antibody 22-1-1 in patients with cholangiocellular carcinoma.
    Watanabe H; Enjoji M; Nakashima M; Noguchi K; Kinukawa N; Sugimoto R; Kotoh K; Nakamuta M; Nawata H; Watanabe T
    J Hepatol; 2003 Oct; 39(4):559-63. PubMed ID: 12971966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer.
    Knychalski B; Lukieńczuk T
    Pol Przegl Chir; 2012 Feb; 84(2):86-92. PubMed ID: 22487741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel serum tumor marker, RCAS1, in pancreatic diseases.
    Yamaguchi K; Enjoji M; Nakashima M; Nakamuta M; Watanabe T; Tanaka M
    World J Gastroenterol; 2005 Sep; 11(33):5199-202. PubMed ID: 16127752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endosialin (TEM1) as a Diagnostic, Progression, and Prognostic Serum Marker for Patients With Colorectal Cancer-A Preliminary Study.
    Pietrzyk Ł; Wdowiak P
    Cancer Control; 2020; 27(1):1073274820903351. PubMed ID: 32107922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating MIC-1/GDF15 is a complementary screening biomarker with CEA and correlates with liver metastasis and poor survival in colorectal cancer.
    Wang X; Yang Z; Tian H; Li Y; Li M; Zhao W; Zhang C; Wang T; Liu J; Zhang A; Shen D; Zheng C; Qi J; Zhao D; Shi J; Jin L; Rao J; Zhang W
    Oncotarget; 2017 Apr; 8(15):24892-24901. PubMed ID: 28206963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and diagnostic evaluation of the human tumor-associated antigen RCAS1 in pancreatic cancer.
    Akashi T; Oimomi H; Nishiyama K; Nakashima M; Arita Y; Sumii T; Kimura T; Ito T; Nawata H; Watanabe T
    Pancreas; 2003 Jan; 26(1):49-55. PubMed ID: 12499917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma circular RNA panel acts as a novel diagnostic biomarker for colorectal cancer.
    Lin J; Cai D; Li W; Yu T; Mao H; Jiang S; Xiao B
    Clin Biochem; 2019 Dec; 74():60-68. PubMed ID: 31669510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor markers for diagnosis, monitoring of recurrence and prognosis in patients with upper gastrointestinal tract cancer.
    Jing JX; Wang Y; Xu XQ; Sun T; Tian BG; Du LL; Zhao XW; Han CZ
    Asian Pac J Cancer Prev; 2014; 15(23):10267-72. PubMed ID: 25556459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical and immunohistochemical study on gastrointestinal mesenchymal tumor (GIMT): RCAS1 as a predictor for recurrence of GIMT.
    Naito A; Narikiyo M; Yamada Y; Ueno M; Kamada K; Hachisuka T; Yoriki R; Mizuno T; Nakajima Y
    Oncol Rep; 2005 Nov; 14(5):1127-32. PubMed ID: 16211275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.